Sponsor

Hangzhou Reprogenix Bioscience, Inc

Clinical research sponsor

Published trials3

Recruiting shown1

Roles2

SourceClinicalTrials.gov

Clinical trials

3 shown

Phase I Clinical Study to Evaluate the Safety and Efficacy of RGB-5088 in Patients With Type 1 Diabetes MellitusNCT06731218 · lead sponsor · 2025-02-17

RECRUITING

A Clinical Study to Evaluate the Safety and Efficacy of RGB-5088 in Patients With Type 2 Diabetes MellitusNCT07794254 · lead sponsor · 2026-09-30

NOT_YET_RECRUITING

A Clinical Study of iPSC-Derived Islet Cells for Diabetes Mellitus TherapyNCT07464119 · collaborator · 2026-03-16

NOT_YET_RECRUITING

Sponsor roles

lead sponsor2

collaborator1

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.